Clinical Pharmacology and Drug Toxicity Practice Questions

Q: A 35-year-old woman presents to the emergency department after ingesting approximately 50 tablets of acetaminophen 4 hours ago in a suicide attempt. Her acetaminophen level is 200 µg/mL. Which of the following best describes the mechanism of toxicity in this case?

Depletion of glutathione stores. ***Depletion of glutathione stores*** - In acetaminophen overdose, the normal metabolic pathways become saturated, leading to the accumulation of a toxic metabolite called **N-acetyl-p-benzoquinone imine (NAPQI)**. - **NAPQI** is normally detoxified by conjugation with **glutathione**, but in overdose, glutathione stores are depleted, allowing NAPQI to bind covalently to hepatocyte macromolecules, causing damage. *Blockade of calcium channels* - This mechanism is characteristic of **calcium channel blocker toxicity**, leading to cardiovascular depression (bradycardia, hypotension) and is not relevant to acetaminophen overdose. - Acetaminophen toxicity primarily affects the liver via a different pathway, not directly interfering with calcium channels. *Direct cellular necrosis* - While acetaminophen overdose ultimately leads to **hepatocellular necrosis**, this is the *result* of the toxicity, not the primary mechanism by which the drug initiates cellular damage. - The necrosis is mediated by the accumulation of the toxic metabolite **NAPQI** and the subsequent oxidative stress and cellular injury, not by direct cellular destruction without prior steps. *Inhibition of cytochrome oxidase* - This mechanism is associated with toxins like **cyanide** and **carbon monoxide**, which impair mitochondrial respiration and cellular energy production. - Acetaminophen toxicity does not directly involve the inhibition of cytochrome oxidase as its primary mechanism of hepatotoxicity.

Q: A 55-year-old man presents to the emergency department with acute confusion, visual disturbances, and difficulty breathing. His wife reports he was working with industrial cleaning supplies in an unventilated space. Laboratory analysis reveals severe metabolic acidosis and elevated anion gap. Which of the following antidotes should be administered immediately?

Hydroxocobalamin. ***Hydroxocobalamin*** - The patient's presentation with **acute confusion**, **visual disturbances**, **difficulty breathing**, and exposure to industrial cleaning supplies in an **unventilated space**, along with **severe metabolic acidosis** and an **elevated anion gap**, is highly suggestive of **cyanide poisoning**. - **Hydroxocobalamin** is a preferred antidote for cyanide poisoning because it directly binds to cyanide, forming cyanocobalamin (vitamin B12), which is then safely excreted, without interfering with oxygen transport in the blood. *Flumazenil* - **Flumazenil** is a benzodiazepine receptor antagonist used to reverse the sedative effects of **benzodiazepine overdose**. - The patient's symptoms (confusion, visual disturbances, metabolic acidosis) are not consistent with benzodiazepine overdose. *Fomepizole* - **Fomepizole** is an alcohol dehydrogenase inhibitor used to treat poisoning by **ethylene glycol** and **methanol**. - While both ethylene glycol and methanol poisoning cause severe metabolic acidosis and elevated anion gap, the patient's exposure to industrial cleaning supplies and the specific symptoms of visual disturbances point more directly towards cyanide than these alcohols. *Naloxone* - **Naloxone** is an opioid antagonist used to reverse **opioid overdose**. - The patient's clinical presentation, including metabolic acidosis and exposure history, does not indicate opioid overdose.

Q: A 62-year-old man, who is known to have recurrent thromboembolic strokes, presents to his physician for a routine follow-up visit. While assessing drug compliance, the physician realizes that the patient inadvertently doubled his dose of warfarin 1 month ago. When he is asked about any new complaints, the patient denies any symptoms, including bleeding. The physical examination does not show any signs of bleeding. Based on the patient’s lifestyle, the physician does not consider him to be at increased risk for bleeding. He then orders an international normalized ratio (INR) for this patient, which is 13.5. In addition to temporarily holding warfarin, which of the following drugs is indicated for this patient?

Phytonadione. ***Phytonadione*** - The patient has a highly elevated **INR (13.5)** due to an overdose of warfarin, a **vitamin K antagonist** [1, 2]. - **Phytonadione (vitamin K1)** - Is the most appropriate treatment to reverse warfarin's anticoagulant effects when there is a high INR but **no significant bleeding**, as it replenishes vitamin K-dependent clotting factors [1, 2]. *Fresh frozen plasma* - While it contains all clotting factors and can rapidly normalize INR, it is generally reserved for **life-threatening bleeding** or urgent invasive procedures when rapid reversal is critical. - Its use comes with risks such as **transfusion reactions** and **volume overload**, which are not justified in this asymptomatic patient. *Protamine sulfate* - This drug is used to reverse the anticoagulant effects of **heparin** and **low molecular weight heparins**, not warfarin. - It would have no effect on the highly elevated INR caused by warfarin. *Recombinant factor VIIa* - This agent is used to bypass deficiencies in the coagulation cascade and achieve rapid hemostasis. - It is typically reserved for **severe, refractory bleeding** that is unresponsive to conventional reversal agents, due to its **high cost** and potential for **thromboembolic complications**.

Q: Antidote for opioid poisoning:

Naloxone. ***Naloxone*** - **Naloxone** is a pure **opioid antagonist** that reverses the effects of opioid overdose by competing for and binding to opioid receptors. - It is crucial in emergent situations to restore **respiratory drive** and consciousness in patients with opioid-induced respiratory depression. *Pethidine* - **Pethidine** is an **opioid analgesic** itself, primarily used for pain management, and would worsen opioid poisoning. - It works by binding to opioid receptors, leading to centrally mediated pain relief, making it contraindicated in overdose. *Flumazenil* - **Flumazenil** is an antagonist for **benzodiazepines**, used to reverse their sedative and respiratory depressant effects. - It has no effect on opioid receptors and would not be effective in treating opioid poisoning. *Physostigmine* - **Physostigmine** is a **cholinesterase inhibitor** used to reverse anticholinergic toxicity. - It increases acetylcholine levels at the synapse and is not indicated for opioid overdose.

Q: Which of the following local anesthetics is the most common cause of methemoglobinemia?

Benzocaine. ***Benzocaine***- **Benzocaine** is an ester-type local anesthetic that is the **most common cause of methemoglobinemia** among local anesthetics, especially when used in high doses or on mucous membranes due to its rapid absorption.- Its metabolic byproducts, particularly **aniline derivatives**, are potent oxidizers of hemoglobin, converting the ferrous iron (Fe2+) to ferric iron (Fe3+), thus forming methemoglobin which cannot bind oxygen.- **FDA warnings** have been issued regarding benzocaine-induced methemoglobinemia, particularly with topical spray preparations.*Lignocaine*- **Lignocaine** (lidocaine) is an amide-type local anesthetic and is **rarely associated** with methemoglobinemia.- While it can theoretically cause it in very high doses, it is significantly **less potent** in this regard compared to benzocaine.*Chloroprocaine*- **Chloroprocaine** is an ester-type local anesthetic with a very **short duration of action** due to rapid hydrolysis by plasma cholinesterases.- This rapid metabolism typically limits systemic exposure and makes it an **uncommon cause** of methemoglobinemia despite being an ester.*Prilocaine*- **Prilocaine** is an amide-type local anesthetic that can also cause methemoglobinemia, particularly at **higher doses (>600mg)** [1, 2].- It works through its metabolite, **o-toluidine**, which is an oxidizing agent [1].- However, **benzocaine** is more consistently linked to this adverse effect in clinical practice and has more documented case reports.

Q: All of the following statements about pralidoxime in organophosphate poisoning are true except:-

It should be started after 24 hours of poisoning. ***It should be started after 24 hours of poisoning*** - **Pralidoxime (2-PAM)** is most effective when administered **early** in organophosphate poisoning, ideally within minutes to a few hours of exposure. - Delaying administration beyond **24-48 hours** significantly reduces its efficacy because the bond between the organophosphate and **acetylcholinesterase (AChE)** becomes **irreversible** (a process called "aging"). *It does not cross blood brain barrier* - **Pralidoxime** is a **quaternary ammonium compound**, which makes it highly polar and unable to readily cross the **blood-brain barrier**. - Therefore, it primarily reactivates **acetylcholinesterase** in the **peripheral nervous system** but has limited effect on central nervous system symptoms. *Reactivates the AChE enzyme* - **Pralidoxime** works by **reactivating the acetylcholinesterase enzyme** that has been inhibited by organophosphates. - It does this by binding to the organophosphate molecule, thereby freeing the active site of the **AChE enzyme** to metabolize **acetylcholine** again. *It is given intravenously* - **Pralidoxime** is typically administered via **intravenous (IV) infusion** to achieve rapid and sustained therapeutic concentrations. - Due to its poor oral absorption, oral administration is not a suitable route for treating acute organophosphate poisoning.

Q: Therapeutic drug monitoring is done for:

Phenytoin. ***Phenytoin*** - **Phenytoin** has a **narrow therapeutic window**, meaning the difference between an effective and a toxic dose is small, necessitating close monitoring. - Its **variable absorption** and **nonlinear pharmacokinetics** (saturable metabolism) make individual dosing adjustments critical to maintain therapeutic levels and avoid toxicity. *Aspirin* - **Aspirin** is generally not monitored via plasma levels for its analgesic or antiplatelet effects, as its therapeutic effects are often observed at doses where plasma monitoring is not practical or necessary. - Its primary therapeutic use as an **antiplatelet agent** is evaluated by clinical outcomes rather than drug concentration. *Heparin* - **Heparin** is monitored using coagulation tests like **aPTT (activated partial thromboplastin time)** or anti-Xa levels to assess its anticoagulant effect, not direct drug concentration. - Therapeutic drug monitoring for heparin focuses on its **pharmacodynamic effects** on the clotting cascade rather than its absolute plasma concentration. *Metformin* - **Metformin** has a relatively **wide therapeutic index** and its efficacy is primarily measured by reductions in blood glucose and HbA1c, not by plasma drug concentrations. - It is excreted largely unchanged by the kidneys, and dose adjustments are typically made based on **renal function** and glycemic control.

Q: All are true about atropine poisoning, except

Decreased temperature. ***Decreased temperature*** - Atropine is an **anticholinergic** agent that blocks muscarinic receptors, leading to decreased sweating and **hyperthermia** (increased temperature) in poisoning. - The phrase **"hot as a hare"** is a classic mnemonic for atropine poisoning, referring to this elevated body temperature. *Dysarthria* - **Dysarthria** (slurred or difficult speech) can be a symptom of atropine poisoning due to the **CNS effects** of anticholinergic toxicity. - Atropine crosses the blood-brain barrier and can cause a range of neurological symptoms including agitation, delirium, and impaired speech. *Dysphagia* - **Dysphagia** (difficulty swallowing) is a common symptom in atropine poisoning, related to the **drying of oral and pharyngeal secretions** due to anticholinergic effects. - The mouth becomes very dry, making it difficult to form a food bolus and swallow effectively. *Dilated pupils* - **Dilated pupils (mydriasis)** unresponsive to light are a hallmark sign of atropine poisoning, as atropine blocks parasympathetic innervation to the iris sphincter muscle. - This symptom is often described in the mnemonic as **"blind as a bat"** due to the associated blurred vision and photophobia.

Q: Antidote for benzodiazepine poisoning: FMGE 10, 13; NEET 14

Flumazenil. ***Flumazenil*** - **Flumazenil** is a competitive **benzodiazepine receptor antagonist** that can reverse the sedative and other central nervous system effects of benzodiazepines. - It works by blocking benzodiazepines from binding to their receptor sites on the **GABA-A receptor complex**. *Naloxone* - **Naloxone** is a competitive **opioid receptor antagonist** used to reverse opioid overdose. - It has no effect on **benzodiazepine toxicity** as it targets different receptor systems. *Atropine* - **Atropine** is an **anticholinergic drug** used to reverse the effects of **cholinergic poisoning** (e.g., from organophosphates, carbamates) or symptomatic bradycardia. - It works on muscarinic acetylcholine receptors and is not involved in benzodiazepine metabolism or action. *N-acetyl-cysteine* - **N-acetyl-cysteine (NAC)** is primarily used as an antidote for **acetaminophen (paracetamol) poisoning**, where it replenishes glutathione. - It is also used in some cases of mucolysis but has no role in reversing benzodiazepine toxicity.

Q: Which of these is the best for management of methanol poisoning?

Fomepizole. ***Fomepizole*** - **Fomepizole** is a competitive inhibitor of **alcohol dehydrogenase**, the enzyme responsible for metabolizing methanol into toxic metabolites like formic acid. - By inhibiting this enzyme, it prevents the formation of these toxic metabolites, thereby reducing organ damage and metabolic acidosis in methanol poisoning. *Naltrexone* - **Naltrexone** is an **opioid receptor antagonist** used in the treatment of alcohol and opioid dependence. - It does not have any direct action on the metabolism of methanol or its toxic byproducts. *Disulfiram* - **Disulfiram** inhibits **aldehyde dehydrogenase**, leading to an unpleasant reaction when alcohol is consumed (flushing, nausea, vomiting). - It is used for alcohol cessation and has no role in the management of methanol poisoning. *Acamprosate* - **Acamprosate** is a medication used to reduce alcohol cravings in individuals recovering from alcohol dependence, possibly by modulating **glutamate neurotransmission**. - It does not directly affect the metabolism of methanol or mitigate its toxic effects.

Question 1

A 35-year-old woman presents to the emergency department after ingesting approximately 50 tablets of acetaminophen 4 hours ago in a suicide attempt. Her acetaminophen level is 200 µg/mL. Which of the following best describes the mechanism of toxicity in this case?

Accepted Answer

Depletion of glutathione stores

Answer

Blockade of calcium channels

Answer

Direct cellular necrosis

Answer

Inhibition of cytochrome oxidase

Question 2

A 55-year-old man presents to the emergency department with acute confusion, visual disturbances, and difficulty breathing. His wife reports he was working with industrial cleaning supplies in an unventilated space. Laboratory analysis reveals severe metabolic acidosis and elevated anion gap. Which of the following antidotes should be administered immediately?

Accepted Answer

Hydroxocobalamin

Answer

Flumazenil

Answer

Fomepizole

Answer

Naloxone

Question 3

A 62-year-old man, who is known to have recurrent thromboembolic strokes, presents to his physician for a routine follow-up visit. While assessing drug compliance, the physician realizes that the patient inadvertently doubled his dose of warfarin 1 month ago. When he is asked about any new complaints, the patient denies any symptoms, including bleeding. The physical examination does not show any signs of bleeding. Based on the patient’s lifestyle, the physician does not consider him to be at increased risk for bleeding. He then orders an international normalized ratio (INR) for this patient, which is 13.5. In addition to temporarily holding warfarin, which of the following drugs is indicated for this patient?

Accepted Answer

Phytonadione

Answer

Fresh frozen plasma

Answer

Protamine sulfate

Answer

Recombinant factor VIIa

Question 4

Antidote for opioid poisoning:

Accepted Answer

Naloxone

Answer

Pethidine

Answer

Flumazenil

Answer

Physostigmine

Question 5

Which of the following local anesthetics is the most common cause of methemoglobinemia?

Accepted Answer

Benzocaine

Answer

Lignocaine

Answer

Chloroprocaine

Answer

EMLA Cream (Lignocaine + Prilocaine)

Answer

Prilocaine

Answer

Dibucaine

Question 6

All of the following statements about pralidoxime in organophosphate poisoning are true except:-

Accepted Answer

It should be started after 24 hours of poisoning

Answer

It does not cross blood brain barrier

Answer

Reactivates the AChE enzyme

Answer

It is given intravenously

Question 7

Therapeutic drug monitoring is done for:

Accepted Answer

Phenytoin

Answer

Aspirin

Answer

Heparin

Answer

Metformin

Question 8

All are true about atropine poisoning, except

Accepted Answer

Decreased temperature

Answer

Dysarthria

Answer

Dysphagia

Answer

Dilated pupils

Question 9

Antidote for benzodiazepine poisoning: FMGE 10, 13; NEET 14

Accepted Answer

Flumazenil

Answer

Naloxone

Answer

Atropine

Answer

N-acetyl-cysteine

Question 10

Which of these is the best for management of methanol poisoning?

Accepted Answer

Fomepizole

Answer

Naltrexone

Answer

Disulfiram

Answer

Acamprosate

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?